Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

14 Nov 2022

Drug developers and payers are coming together long before product approvals to work out payment options for high-cost, high-impact cell and gene therapies, but challenges like portability of commercially insured patients and Medicaid best price requirements remain.

ターゲット市場の実像をつかむ

Datamonitor Healthcare's Top Research Reports

27 Nov 2020

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Competitive Strategies Critical As EMA Decides On Kymriah And Yescarta

27 Nov 2020

With Novartis’s and Kite’s CAR T-cell therapies both expected to gain recommendations for pan-EU approval this week, discounts will need to be negotiated for these new treatments to reach the markets in Europe.

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Quick Listen: Scrip's Five Must-Know Things

03 Sep 2020

Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース, Scrip: 世界の医...

Webinar: Is Biopharma Fit For the New Decade?

11 Mar 2020

Download your article pack now for a glimpse of some of the topics that will be covered by our panel of experts during the “Is Biopharma Fit for the New Decade?” webinar.

Adoptive Cell Therapy

03 Feb 2020

Citeline recently introduced a new Therapeutic Class called "Adoptive cell therapy", enabling more granular searching capabilities to hone in on this exciting cancer immunotherapy that is expanding the horizon of personalized medicine